ENGN FY 2021 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$16M

Net Income

-$23M

EPS (Diluted)

$-0.01

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$435,000

Balance Sheet

Total Assets

$131M

Total Liabilities

$4M

Stockholders' Equity

$127M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$16M	-$14M	-14.6%
Net Income	-$23M	-$15M	-55.6%